Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology

British Journal of Dermatology

Volumn 176, Issue 5, 2017, Pages 1351-1353

  Goon, P K C ^a   Greenberg, D C ^b   Igali, L ^a   Levell, N J ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER INCIDENCE; DERMATOLOGY; HEALTH CARE PLANNING; HISTOPATHOLOGY; HUMAN; LETTER; NON MELANOMA SKIN CANCER; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRIORITY JOURNAL; RESOURCE ALLOCATION; SQUAMOUS CELL SKIN CARCINOMA; UNITED KINGDOM; COST; ECONOMICS; ENGLAND; FORECASTING; INCIDENCE; NATIONAL HEALTH SERVICE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COSTS AND COST ANALYSIS; ENGLAND; FORECASTING; HUMANS; INCIDENCE; SKIN NEOPLASMS; STATE MEDICINE;

EID: 85007108786     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15110     Document Type: Letter

References (3)

1. Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the U.K.: the elephant in the room. Clin Exp Dermatol 2013; 38:367–9.
2. Goon PK, Greenberg DC, Igali L, Levell NJ. Squamous cell carcinoma of the skin has more than doubled over the last decade in the U.K. Acta Derm Venereol 2016; 96:820–1.
3. Vallejo-Torres L, Morris S, Kinge JM et al. Measuring current and future cost of skin cancer in England. J Public Health (Oxf) 2014; 36:140–8.